Global Pharmaceutical Granulator Market Strategic Research Report

Scope of the Report

The global Pharmaceutical Granulator market size is predicted to grow from US$ 749 million in 2025 to US$ 1,080 million in 2032; it is expected to grow at a CAGR of 5.4% from 2026 to 2032.

In 2025, global Pharmaceutical Granulator production reached approximately 5.1k units, with an average global market price of around US$150k per unit.

A Pharmaceutical Granulator is a key piece of equipment used in pharmaceutical manufacturing to convert powdered raw materials into granules with controlled particle size, density, flowability, and compressibility. It is widely utilized in the production of tablets, capsules, granules, and other solid dosage forms. The equipment operates through processes such as mixing, agitation, compaction, extrusion, fluidization, or spray granulation, enabling active pharmaceutical ingredients (APIs) and excipients to be uniformly combined and transformed into stable granules. This process improves powder flow characteristics, content uniformity, and compression performance, thereby enhancing the efficiency and consistency of downstream operations such as tableting, capsule filling, coating, and packaging. Depending on the manufacturing process, pharmaceutical granulators are commonly categorized into wet granulators, dry granulators, fluid bed granulators, and high-shear granulators. As one of the core systems in modern solid dosage pharmaceutical production lines, pharmaceutical granulators are extensively used in chemical pharmaceuticals, biopharmaceuticals, traditional medicines, nutraceuticals, and veterinary drugs. With increasing regulatory requirements and advancements in pharmaceutical manufacturing, the industry is moving toward highly automated, continuous, intelligent, and GMP-compliant granulation solutions.

The upstream segment of the pharmaceutical granulator industry includes suppliers of stainless steel materials, precision mechanical components, motors, gear reducers, PLC control systems, sensors, and automation components. Representative suppliers include Siemens, Schneider Electric, ABB, and SEW-Eurodrive. The midstream sector consists of pharmaceutical equipment manufacturers such as GEA Group, Syntegon, Freund Corporation. Downstream customers mainly include pharmaceutical and nutraceutical manufacturers such as Pfizer, Novartis, Johnson & Johnson, and Sinopharm.

The pharmaceutical granulator market continues to develop steadily, supported by the expansion of pharmaceutical manufacturing, increasing generic drug production, and growing demand for advanced solid dosage formulations. Rising GMP requirements and the need for higher production efficiency, product consistency, and automation are accelerating the adoption of high-shear, fluid bed, and continuous granulation technologies. Future development is expected to focus on intelligent automation, continuous processing, digital manufacturing, and enhanced hygienic design. However, stringent validation requirements, substantial R&D investment needs, and fluctuations in capital expenditure within the pharmaceutical industry remain important challenges for equipment suppliers.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Granulator market?

What factors are driving Pharmaceutical Granulator market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Granulator market opportunities vary by end market size?

How does Pharmaceutical Granulator break out by Type, by Application?

This report presents a comprehensive overview of the global Pharmaceutical Granulator market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Dry Granulation
• Moist Granulation

Segment by Automation Level

• Semi-Automatic
• Fully Automatic

Segment by Production Capacity

• ≤100 kg/h
• 100–500 kg/h
• 500–1000 kg/h
• ≥1000 kg/h

Segment by Application

• Chemical Pharmaceuticals
• Biopharmaceuticals
• Traditional Chinese Medicine
• Nutraceuticals
• Veterinary Pharmaceuticals
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pharmaceutical Granulator market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Chemical Pharmaceuticals, Biopharmaceuticals, Traditional Chinese Medicine evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact